0

Rapid Tests Market: Current Analysis and Forecast (2021-2027)

Region:Global

Author(s):

Product Code:UMHE21298

Download Sample Report download
Buy the Full ReportStarting from $3500
Published on

July 2021

Total pages

128

Table of Content

Download Sample Report download
Buy the Full ReportStarting from $3500

About the Report

About the Report

Rapid tests are parasite-based diagnosis tests in cases where microscopy is not possible. These tests are designed to be used in point-of-care (POC) and are adapted for use in low-resource setting. Rapid tests are low-cost, simple to use, specific, sensitive, stable, and high temperatures. These tests are being used for a variety of diseases.

Rapid Tests can be used in settings with minimally trained healthcare professionals, additionally, the samples can be collected non-invasively or with low invasion such as blood extraction from capillaries. There are a variety of platforms for rapid tests, each with their own benefits and limitations. Mechanism of these tests are usually based on immunoassay technology, where a fixed reagent can react with the target antigen or antibody and is linked to some type of a visible detector which then reacts to the sample of the patient. In addition to their use as diagnostic tools, rapid tests can also be used as epidemiological tools. It enables the rapid screening of a potentially affected population and can be used with lymphatic filariasis to test if a mass drug administration has been successful. Rapid tests are less necessary in diseases that can be syndromically identified, but it can also prevent over prescription of antibiotics.

Based on product type, the rapid tests market is segmented into Over the counter (OTC) Rapid Test Product, and Professional Rapid Test Product. Amongst product type, the professional rapid tests segment of the rapid tests market was valued at USD XX billion in 2020 and is likely to reach USD XX billion by 2027.

Based on application, the rapid tests market is segmented into Infectious Disease, Cardiology, Oncology, Pregnancy & Fertility, Toxicology, Glucose Monitoring, and Others. The infectious disease segment is further fragmented into HPV, Hepatitis, Influenza, Malaria, HIV, and Others. Amongst application, infectious diseases accounted for a market valuation of USD XX billion in 2020 and is expected to reach USD XX billion by the year 2027, at a CAGR of XX% over the analyzed period.

Based on end-user, the rapid tests market is segmented into Hospital & Clinic, Diagnostic Laboratory, Home Care, and Others. The hospital & clinic segment generated revenue of USD XX billion in 2020 and is expected to grow at a CAGR of XX% during the forecast period to reach a market valuation of USD XX billion by 2027F.

For a better understanding of the market adoption of Rapid Tests Industry, the market is analyzed based on its worldwide presence in the countries such as North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, Australia, and Rest of APAC), and Rest of World. North America will dominate the Rapid Tests market on account of the increasing infectious diseases which are on the rise all over the world.

Some of the major players operating in the market include ACON Laboratories, Inc., Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton, Dickinson and Company, BTNX, Inc., bioMerieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., Danaher Corporation. Several M&As along with partnerships have been undertaken by these players to boost their presence in different regions.

Products


Companies

ACON Laboratories, Inc., Abbott Laboratories, Artron Laboratories Inc., Alfa Scientific Designs, Inc., Becton, Dickinson and Company, BTNX, Inc., bioMerieux SA, Cardinal Health, Bio-Rad Laboratories, Inc., and Danaher Corporation

Table of Contents

Table of Contents

1 MARKET INTRODUCTION

1.1. Market Definitions

1.2. Objective of the Study

1.3. Limitation

1.4. Stake Holders

1.5. Currency Used in Report

1.6. Scope of the Rapid Tests Market Study

2 RESEARCH METHODOLOGY OR ASSUMPTION

2.1. Research Methodology for the Rapid Tests Market

2.1.1. Main Objective of the Rapid Tests Market

3 INDUSTRY PERFORMANCE

4 EXECUTIVE SUMMARY

5 COVID-19 IMPACT

6 MARKET INSIGHTS BY PRODUCT TYPE

6.1. Over-the-counter (OTC) Rapid Test Product

6.2. Professional Rapid Test Product

7 MARKET INSIGHTS BY APPLICATION

7.1. Infectious Disease

7.1.1. HPV

7.1.2. Hepatitis

7.1.3. Influenza

7.1.4. Malaria

7.1.5. HIV

7.1.6. Others

7.2. Cardiology

7.3. Oncology

7.4. Pregnancy & Fertility

7.5. Toxicology

7.6. Glucose Monitoring

7.7. Others

8 MARKET INSIGHTS BY END-USER

8.1. Hospital & Clinic

8.2. Diagnostic Laboratory

8.3. Home Care

8.4. Others

9 MARKET INSIGHTS BY REGION

9.1. NORTH AMERICA RAPID TESTS MARKET

9.1.1. United States of America

9.1.2. Canada

9.1.3. Rest of North America

9.2. EUROPE RAPID TESTS MARKET

9.2.1. United Kingdom

9.2.2. Germany

9.2.3. France

9.2.4. Spain

9.2.5. Italy

9.2.6. Rest of Europe

9.3. ASIA-PACIFIC RAPID TESTS MARKET

9.3.1. China

9.3.2. Japan

9.3.3. India

9.3.4. Australia

9.3.5. Rest of Asia-Pacific

9.4. REST OF THE WORLD RAPID TESTS MARKET

10 LEGAL AND REGULATORY FRAMEWORK

11 DEMAND AND SUPPLY SIDE ANALYSIS

11.1. Demand Side Analysis

11.2. Supply Side Analysis

11.2.1. Top Product Launches

11.2.2. Top Business Partnerships

11.2.3. Top Business Expansions, Investments and Divestitures

11.2.4. Top Merger and Acquisitions

12 VALUE CHAIN ANALYSIS

13 RAPID TESTS MARKET TRENDS & INSIGHTS

14 RAPID TESTS MARKET DYNAMICS

14.1. Drivers

14.2. Challenges

14.3. Impact Analysis

14.4. Opportunity

15 COMPETITIVE SCENARIO

15.1. Rapid Tests Market Share, by Company 2020

16 COMPANY PROFILED

16.1. ACON Laboratories, Inc.

16.2. Abbott Laboratories

16.3. Artron Laboratories Inc.

16.4. Alfa Scientific Designs, Inc.

16.5. Becton, Dickinson and Company

16.6. BTNX, Inc.

16.7. bioMerieux SA

16.8. Cardinal Health

16.9. Bio-Rad Laboratories, Inc.

16.10. Danaher Corporation

17 DISCLAIMER

You can also purchase parts of this report.
Do you want to check out a section wise price list?
Get Price Break-up

Why Buy From US?

RRR
Refine Robust Result (RRR) Framework

What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story

reach
Our Reach Is Unmatched

We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.

Research
Shifting the Research Paradigm

While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.

Insite
More Insights-Better Decisions

With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.

Trust
Transparency and Trust

Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.

support
Round the Clock Support

If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.

Why Client Choose Us?

400000+ Reports in repository
150+ Consulting project a year
100+ Analysts
8000+ Client Queries in 2022